HIMCH
TEVA icon

Hartford Investment Management Co (HIMCO)’s Teva Pharmaceuticals TEVA Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$429K Buy
12,677
+550
+5% +$18.3K 0.01% 482
2026
Q1 		$365K Sell
12,127
-1,664
-12% -$53.5K 0.01% 487
2025
Q4 		$430K Sell
13,791
-53
-0.4% -$1.31K 0.01% 481
2025
Q3 		$280K Buy
13,844
+48
+0.3% +$843 0.01% 491
2025
Q2 		$231K Buy
13,796
+3,257
+31% +$52.6K 0.01% 496
2025
Q1 		$162K Sell
10,539
-49
-0.5% -$875 0.01% 495
2024
Q4 		$233K Buy
10,588
+26
+0.2% +$473 0.01% 495
2024
Q3 		$190K Buy
10,562
+51
+0.5% +$893 0.01% 493
2024
Q2 		$171K Buy
10,511
+180
+2% +$2.77K 0.01% 497
2024
Q1 		$146K Buy
10,331
+10
+0.1% +$126 0.01% 497
2023
Q4 		$108K Hold
10,321
– – ﹤0.01% 497
2023
Q3 		$105K Buy
10,321
+204
+2% +$1.9K ﹤0.01% 510
2023
Q2 		$76.2K Buy
+10,117
New +$82K ﹤0.01% 511
2022
Q3 		– Sell
-13,006
Closed -$98K – 549
2022
Q2 		$98K Sell
13,006
-21
-0.2% -$183 ﹤0.01% 540
2022
Q1 		$122K Sell
13,027
-7,084
-35% -$59.1K ﹤0.01% 538
2021
Q4 		$161K Sell
20,111
-169
-0.8% -$1.52K ﹤0.01% 541
2021
Q3 		$198K Sell
20,280
-3,045
-13% -$28.5K 0.01% 542
2021
Q2 		$231K Sell
23,325
-433
-2% -$4.58K 0.01% 536
2021
Q1 		$274K Sell
23,758
-2,481
-9% -$28.4K 0.01% 534
2020
Q4 		$253K Sell
26,239
-9
-0% -$86 0.01% 526
2020
Q3 		$236K Sell
26,248
-699
-3% -$7.39K 0.01% 517
2020
Q2 		$332K Buy
26,947
+229
+0.9% +$2.59K 0.01% 505
2020
Q1 		$240K Buy
26,718
+417
+2% +$4.27K 0.01% 529
2019
Q4 		$258K Sell
26,301
-1,538
-6% -$13.7K 0.01% 541
2019
Q3 		$192K Sell
27,839
-485
-2% -$3.72K 0.01% 546
2019
Q2 		$261K Buy
28,324
+1,748
+7% +$21.1K 0.01% 523
2019
Q1 		$417K Sell
26,576
-3,005
-10% -$53K 0.01% 512
2018
Q4 		$456K Buy
29,581
+902
+3% +$18.5K 0.01% 526
2018
Q3 		$618K Sell
28,679
-1,150
-4% -$26.7K 0.02% 524
2018
Q2 		$725K Buy
29,829
+1,757
+6% +$35.8K 0.02% 506
2018
Q1 		$480K Sell
28,072
-2,982
-10% -$58.2K 0.01% 552
2017
Q4 		$588K Sell
31,054
-102
-0.3% -$1.53K 0.01% 550
2017
Q3 		$548K Sell
31,156
-519
-2% -$11.7K 0.01% 552
2017
Q2 		$1.05M Sell
31,675
-2,950
-9% -$91.3K 0.02% 534
2017
Q1 		$1.11M Sell
34,625
-12,357
-26% -$422K 0.02% 530
2016
Q4 		$1.7M Buy
+46,982
New +$1.88M 0.03% 491

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s TEVA Position: Q2 2026 in Review

Hartford Investment Management Co (HIMCO) increased its Teva Pharmaceuticals (TEVA) stake by 4.5% in Q2 2026, buying an estimated $18.3K and bringing the position to 12,677 shares worth $429K. The position accounts for 0.01% of the portfolio, ranked #482.

Hartford Investment Management Co (HIMCO) first reported a position in TEVA in Q4 2016 and has held it in 36 quarters since. The position peaked at $1.7M in Q4 2016. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Hartford Investment Management Co (HIMCO) held 12,677 shares of Teva Pharmaceuticals worth $429K as of Q2 2026.
  • Hartford Investment Management Co (HIMCO) bought 550 Teva Pharmaceuticals shares in Q2 2026, an estimated $18.3K.
  • Teva Pharmaceuticals made up 0.01% of Hartford Investment Management Co (HIMCO)'s portfolio in Q2 2026, its #482 holding.
  • Hartford Investment Management Co (HIMCO) first reported a position in Teva Pharmaceuticals in Q4 2016 and has held it in 36 quarters since.
  • Hartford Investment Management Co (HIMCO)'s Teva Pharmaceuticals position peaked at $1.7M in Q4 2016.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q2 2026, filed 15 Jul 2026.